UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enhanced Oral Absorption of Amisulpride Via a Nanostructured Lipid Carrier-Based Capsules: Development, Optimization Applying the Desirability Function Approach and In Vivo Pharmacokinetic Study

AAPS PharmSciTech, 2019-02, Vol.20 (2), p.82-82, Article 82

2019

Volltextzugriff (PDF)

Amisulpride steady-state plasma concentration and adverse reactions in patients with schizophrenia: a study based on therapeutic drug monitoring data

International clinical psychopharmacology, 2022-11, Vol.37 (6), p.255

2022

Volltextzugriff (PDF)

Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late‐onset schizophrenia‐like psychosis (VLOSLP)

International journal of geriatric psychiatry, 2018-02, Vol.33 (2), p.396-404

2018

Volltextzugriff (PDF)

Discovery and Model‐Informed Drug Development of a Controlled‐Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain

Clinical pharmacology and therapeutics, 2024-08, Vol.116 (2), p.460-470

2024

Volltextzugriff (PDF)

A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design

European archives of psychiatry and clinical neuroscience, 2020-02, Vol.270 (1), p.83-94

2020

Volltextzugriff (PDF)

A rapid FTIR spectroscopic assay for quantitative determination of Memantine hydrochloride and Amisulpride in human plasma and pharmaceutical formulations

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2020-08, Vol.236, p.118377, Article 118377

2020

Volltextzugriff (PDF)

An overview of intravenous amisulpride as a new therapeutic option for the prophylaxis and treatment of postoperative nausea and vomiting

Expert opinion on pharmacotherapy, 2020-03, Vol.21 (5), p.517-522

2020

Volltextzugriff (PDF)

A Postoperative Nausea and Vomiting Update

Advances in anesthesia, 2023-12, Vol.41 (1), p.17-38

2023

Volltextzugriff (PDF)

Amisulpride Decreases Tau Protein Hyperphosphorylation in the Brain of OXYS Rats

Current Alzheimer research, 2023-01, Vol.20 (7), p.496-505

2023

Volltextzugriff (PDF)

Amisulpride attenuates 5-fluorouracil-induced cognitive deficits via modulating hippocampal Wnt/GSK-3β/β-catenin signaling in Wistar rats

International immunopharmacology, 2023-11, Vol.124, p.110945-110945, Article 110945

2023

Volltextzugriff (PDF)

A pharmacological profile of intravenous amisulpride for the treatment of postoperative nausea and vomiting

Expert review of clinical pharmacology, 2020-04, Vol.13 (4), p.331-340

2020

Volltextzugriff (PDF)

Does partial blockade of dopamine D2 receptors with Amisulpride cause anhedonia? An experimental study in healthy volunteers

Journal of psychiatric research, 2023-02, Vol.158, p.409-416

2023

Volltextzugriff (PDF)

Phenotypic factors associated with amisulpride‐induced weight gain in first‐episode psychosis patients (from the OPTiMiSE cohort)

Acta psychiatrica Scandinavica, 2019-09, Vol.140 (3), p.283-290

2019

Volltextzugriff (PDF)

Metformin in the Treatment of Amisulpride-Induced Hyperprolactinemia: A Clinical Trial

Frontiers in molecular neuroscience, 2022-05, Vol.15, p.892477-892477

2022

Volltextzugriff (PDF)

Remission in schizophrenia spectrum disorders: A randomized trial of amisulpride, aripiprazole and olanzapine

Schizophrenia research, 2024-09, Vol.271, p.9-18

2024

Volltextzugriff (PDF)

Amisulpride Reduces Craving in Patients with GBL Addiction - Case Series and Review of the Literature

Psychiatria Danubina, 2021, Vol.33 (Suppl 4), p.1235-1237

2021

Volltextzugriff (PDF)

Sonic hedgehog pathway as a new target of atypical antipsychotics: Revisiting of amisulpride and aripiprazole effects in a rat model of schizophrenia

Life sciences (1973), 2023-03, Vol.316, p.121366-121366, Article 121366

2023

Volltextzugriff (PDF)

Cyclic vomiting syndrome responding to amisulpride – A case report

Indian journal of physiology and pharmacology, 2021-12, Vol.65, p.201-203, Article 201

Ram, Dushad

2021

Volltextzugriff (PDF)

A process model account of the role of dopamine in intertemporal choice

eLife, 2023-03, Vol.12

2023

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Amisulpride as Treatment of Established Postoperative Nausea and Vomiting in Patients Who Have Had No Prior Prophylaxis

Anesthesia and analgesia, 2019-06, Vol.128 (6), p.1098

2019

Volltextzugriff (PDF)

When to Use Amisulpride in Adolescents: A Retrospective Chart Examination of Inpatients

Journal of clinical psychopharmacology, 2022-05, Vol.42 (3), p.247-253

2022

Volltextzugriff (PDF)

Treatment of First-Episode Schizophrenia in a Young Woman

JAMA psychiatry (Chicago, Ill.), 2020-02, Vol.77 (2), p.211

2020

Volltextzugriff (PDF)

Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: In vitro and in vivo pharmacological studies

International journal of pharmaceutics, 2021-09, Vol.607, p.121050-121050, Article 121050

2021

Volltextzugriff (PDF)

Cognitive Effects of Combined Amisulpride and Quetiapine Treatment in Patients With Refractory Schizophrenia: A Naturalistic, Prospective Study

American journal of therapeutics, 2020-07, Vol.27 (4), p.e346-e355

2020

Volltextzugriff (PDF)

1 – 25 von 664

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(619)
Mit Volltextzugriff
(517)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Amisulpride
(603)
Science & Technology
(525)
Life Sciences & Biomedicine
(503)
Humans
(400)
Sulpiride - Analogs & Derivatives
(318)
Psychiatry
(297)
Male
(286)
Pharmacology & Pharmacy
(243)
Female
(228)
Adult
(217)
Schizophrenia
(213)
Biological And Medical Sciences
(183)
Schizophrenia - Drug Therapy
(183)
Medical Sciences
(179)
Antipsychotic Agents - Therapeutic Use
(177)
Pharmacology. Drug Treatments
(167)
Antipsychotic Agents - Adverse Effects
(160)
Sulpiride - Therapeutic Use
(154)
Neurosciences & Neurology
(148)
Psychology. Psychoanalysis. Psychiatry
(144)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Enhanced Oral Absorption of Amisulpride Via a Nanostructured Lipid Carrier-Based Capsules: Development, Optimization Applying the Desirability Function Approach and In Vivo Pharmacokinetic Study

Amisulpride steady-state plasma concentration and adverse reactions in patients with schizophrenia: a study based on therapeutic drug monitoring data

Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late‐onset schizophrenia‐like psychosis (VLOSLP)

Discovery and Model‐Informed Drug Development of a Controlled‐Release Formulation of Nonracemic Amisulpride that Reduces Plasma Exposure but Achieves Pharmacodynamic Bioequivalence in the Brain

A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design

A rapid FTIR spectroscopic assay for quantitative determination of Memantine hydrochloride and Amisulpride in human plasma and pharmaceutical formulations

An overview of intravenous amisulpride as a new therapeutic option for the prophylaxis and treatment of postoperative nausea and vomiting

A Postoperative Nausea and Vomiting Update

Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With Schizophrenia

Amisulpride Decreases Tau Protein Hyperphosphorylation in the Brain of OXYS Rats

Amisulpride attenuates 5-fluorouracil-induced cognitive deficits via modulating hippocampal Wnt/GSK-3β/β-catenin signaling in Wistar rats

A pharmacological profile of intravenous amisulpride for the treatment of postoperative nausea and vomiting

Does partial blockade of dopamine D2 receptors with Amisulpride cause anhedonia? An experimental study in healthy volunteers

Phenotypic factors associated with amisulpride‐induced weight gain in first‐episode psychosis patients (from the OPTiMiSE cohort)

Metformin in the Treatment of Amisulpride-Induced Hyperprolactinemia: A Clinical Trial

Remission in schizophrenia spectrum disorders: A randomized trial of amisulpride, aripiprazole and olanzapine

Amisulpride Reduces Craving in Patients with GBL Addiction - Case Series and Review of the Literature

Sonic hedgehog pathway as a new target of atypical antipsychotics: Revisiting of amisulpride and aripiprazole effects in a rat model of schizophrenia

Cyclic vomiting syndrome responding to amisulpride – A case report

A process model account of the role of dopamine in intertemporal choice

Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Amisulpride as Treatment of Established Postoperative Nausea and Vomiting in Patients Who Have Had No Prior Prophylaxis

When to Use Amisulpride in Adolescents: A Retrospective Chart Examination of Inpatients

Treatment of First-Episode Schizophrenia in a Young Woman

Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: In vitro and in vivo pharmacological studies

Cognitive Effects of Combined Amisulpride and Quetiapine Treatment in Patients With Refractory Schizophrenia: A Naturalistic, Prospective Study

Suchergebnisse filtern